Can pravastatin sodium raise blood glucose and increase the risk of diabetes?

Some evidence suggests that pravastatin sodium, as a statin, can raise blood glucose and, in patients at high risk of diabetes, cause hyperglycaemia requiring diabetes care; however, vascular benefits outweigh this risk, so it is not a reason to stop treatment.